Bone age as a correction factor for the analysis of trabecular bone score (TBS) in children.


Journal

Archives of osteoporosis
ISSN: 1862-3514
Titre abrégé: Arch Osteoporos
Pays: England
ID NLM: 101318988

Informations de publication

Date de publication:
27 02 2019
Historique:
received: 03 12 2018
accepted: 27 01 2019
entrez: 1 3 2019
pubmed: 1 3 2019
medline: 18 2 2020
Statut: epublish

Résumé

Trabecular bone score (TBS) is a tool to improve evaluation of DXA scans, barely used in children. We proposed to evaluate TBS with bone age (BA) compared to chronological age (CA). In girls, TBS value using BA is constant until age 8, and in boys until age 10, and then starts to increase steadily. This data may help widen TBS use in pediatric populations. Trabecular bone score (TBS) is a software-based tool for the analysis of DXA images to assess bone microarchitecture in the lumbar region. It is used widely in adults to improve evaluation of fracture risk, yet it has been rarely studied in children and no normal curves have been developed for pediatrics. The purpose of this study was to evaluate bone (skeletal) age compared to chronological age to determine which is better in the pediatric population since both bone age (BA) and trabecular density are equally susceptible to change in response to similar factors. Total body, lumbar region, and non-dominant hand scans were obtained with an iDXA device in all participants. DXA scans of lumbar region for TBS analysis and AP images of non-dominant hand-for-BA were obtained for 565 children (269 female) aged 4to 19. Simple correlation was calculated and r The use of BA in the analysis and interpretation of TBS may help widen its use in pediatric populations by enabling the appearance of normative data, but more information is needed to confirm this finding.

Identifiants

pubmed: 30815747
doi: 10.1007/s11657-019-0573-6
pii: 10.1007/s11657-019-0573-6
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

26

Auteurs

Miguel Angel Guagnelli (MA)

Clinical Epidemiology Unit, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.

Renaud Winzenrieth (R)

R&D Department, Med-Imaps, Pessac, France.

Desiree Lopez-Gonzalez (D)

Clinical Epidemiology Unit, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.

Michael R McClung (MR)

Oregon Osteoporosis Center, Portland, OR, USA.
AustralianCatholicUniversity, Melbourne, Australia.

Luis Del Rio (L)

CETIR Medical Centre, Barcelona, Spain.

Patricia Clark (P)

Clinical Epidemiology Unit, Hospital Infantil de México Federico Gómez, Mexico City, Mexico. patriciaclark@prodigy.net.mx.
Facultad de Medicina, UNAM, Mexico City, Mexico. patriciaclark@prodigy.net.mx.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH